Review of the COVID-19 Risk in Multiple Sclerosis

The ongoing pandemic of the novel coronavirus of 2019 (COVID-19) has resulted in over 1 million deaths, primarily affecting older patients with chronic ailments. Multiple sclerosis (MS) patients have been deemed particularly vulnerable given their high rates of disability and increased susceptibilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhry, Farhan, Jageka, Cristina, Levy, Phillip D., Cerghet, Mirela, Lisak, Robert P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098748/
https://www.ncbi.nlm.nih.gov/pubmed/33959727
http://dx.doi.org/10.33696/immunology.3.080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098748/
https://www.ncbi.nlm.nih.gov/pubmed/33959727
http://dx.doi.org/10.33696/immunology.3.080

Ejemplares similares